Cosunter(SZ:300436)2022-12-08 01:18Group 1: Company Overview and Sales Model - The company employs both direct sales and distribution models, covering over 1,000 hospitals across regions like Beijing, Shanghai, Fujian, and Tianjin [1] - The sales team consists of more than 200 personnel [1] Group 2: Product Promotion and Market Strategy - The marketing department is responsible for promoting the company's drugs at various relevant conferences, showcasing clinical data from specialists [2] - A general trend of price decline in bidding processes is anticipated, although sales volume may increase [2] - The company plans to expand its sales network into second and third-tier cities to enhance market penetration [2] Group 3: Future Developments and Revenue Growth - The company is currently unable to estimate revenue growth over the next five years due to uncertainties in bidding policies and drug approval processes [2] - The joint venture with Beijing Boao aims to develop a genetic testing platform and precision treatment for hepatitis B [3] - The strategic goal is to provide scientific solutions for liver health in China while exploring suitable merger and acquisition opportunities [3]